Peru | †Risk compensation, effectiveness, side effects | †Low educational level, cost-effectiveness, access to key groups | †Stigma, religious and political barriers, access to key groups |
‡Religious and political barriers, adherence, training providers and users | ‡Adherence, stigma, side effects | ‡Side effects, risk compensation, adherence |
§Demand (lack or excess), access to key groups | §Training providers and users, risk compensation | §Resistance, government support |
Ukraine | †Cost-effectiveness, side effects, increase in STIs | †Adherence, side effects, training providers | †Government willingness, adherence, training providers |
‡Adherence, access to key groups, black market | ‡Cost, supply, government support | ‡Side effects, HIV testing, cost |
§Implementation, government support | §Religious barriers, risk compensation | §Resistance, black market |
India | †Efficacy, need for local trials, risk compensation | †Risk compensation, stigma, lack of awareness | †Risk compensation, efficacy, need for local trials |
‡Users mistrust, adherence, supply | ‡Adherence, HIV testing, users' accessibility | ‡Supply, adherence, access to key groups |
§Resistance, side effects | §Resistance, side effects | §Stigma, religious and political barriers |
Kenya | †Supply, programme complexity, HIV testing | †Risk compensation, cost, adherence | †Cost, training users, resistance |
‡Resistance, limited ART coverage, HWs' workload | ‡Access to key groups, misconceptions and rumours, limited ART coverage | ‡Limited ART coverage, supply, adherence |
§Black market, side effects | §Supply, HWs' workload | §Access to key groups, programme complexity |
Uganda | †Cost, limited ART coverage, adherence | †Cost, limited ART coverage, resistance | †Cost, limited ART coverage, user acceptability |
‡Risk compensation, sustainability, government support | ‡Adherence, criminalisation and stigma, risk compensation | ‡Risk compensation, adherence, sustainability |
§Information and training, HW training and workload | §Side effects, information and training | §Resistance, information and training |
Botswana | †Risk compensation, HIV status disclosure, side effects | †Adherence, cost, resistance | †Cost-effectiveness, risk compensation, implementation |
‡Adherence, resistance, religious barriers | ‡Efficacy, increase in STIs, information and training | ‡Resistance, criminalisation and stigma, limited ART coverage |
§Cost-effectiveness, long-term regimen | §Risk compensation, HWs workload and levels | §Adherence, side effects |
South Africa | †Cost-effectiveness, adherence, cost | †Adherence, healthcare system overload, risk compensation | †Risk compensation, adherence, cost |
‡Sustainability, side effects, risk compensation | ‡Information and training, cost, limited ART coverage | ‡Government support, side effects, information and training |
§Resistance, defining eligibility criteria | §Side effects, effectiveness | §Effectiveness, healthcare system overload |